Plant-derived immunomodulators in cancer: Balancing immune activation and suppression within the tumor microenvironment
{{output}}
The immune system is central to the prevention and control of cancer, yet tumors evolve multiple strategies to subvert immune surveillance. Checkpoint inhibitors targeting CTLA-4, PD-1, and PD-L1 have revolutionized oncology by demonstrating that therapeutic r... ...
